More States Move to Expand Emergency Ban on ‘Gas Station Morphine’

State and local governments across the United States are racing to expand emergency bans on tianeptine, a quasi-legal opioid-like substance sold in convenience stores and often branded as “gas station morphine,” as reports of overdoses and poison control calls continue to climb.

From Niche Antidepressant to Convenience Store Risk

Tianeptine was developed decades ago in Europe as an antidepressant, but it was never approved as a medication in the United States. Publicly available medical information shows that the compound acts on the same brain receptors as opioids such as morphine and oxycodone, which helps explain its powerful withdrawal symptoms and overdose potential when misused.

In many U.S. communities, tianeptine has entered the market not through pharmacies but through gas stations, vape shops and small retailers. Products frequently appear as energy shots, mood enhancers or focus supplements, often with brightly colored labels and vague ingredient lists. Investigative coverage indicates that some items list tianeptine in fine print, while others are marketed as “dietary supplements” despite the absence of federal approval.

Federal regulators have repeatedly warned that tianeptine is not a legal dietary ingredient and that using it can lead to serious health consequences, including confusion, rapid heartbeat, drowsiness, respiratory depression and coma. Reports from poison control centers highlight that many people who experience complications believed they were consuming a benign over-the-counter product, rather than a substance with opioid-like effects.

This disconnect between how tianeptine is sold and how it behaves in the body has fueled the “gas station morphine” label and made the substance a growing focus of state-level emergency actions.

Emergency Bans Spread as Poison Center Calls Rise

In the absence of a federal scheduling decision, states have taken the lead by imposing temporary or emergency bans that can be renewed or converted into permanent restrictions. Over the past several years, early adopters such as Michigan and Tennessee classified tianeptine as a controlled substance, and more states have followed, citing escalating poison center data and local overdose clusters.

Trend reports from public health agencies show that calls to U.S. poison centers involving tianeptine have risen from just a handful in the early 2010s to hundreds annually in recent years. Analysts note that spikes in certain states often correlate with the arrival of particular branded products, such as flavored “brain booster” or “relaxation” shots, which quickly gain popularity through word of mouth and social media.

Emergency rulemaking has become a common tool for governors, attorneys general and pharmacy boards seeking to act quickly. In several states, emergency rules have temporarily banned the manufacture, sale or possession of tianeptine products while lawmakers draft legislation to schedule the substance alongside traditional opioids. Public records show that these rapid actions are often triggered by clusters of emergency room visits, overdose deaths or local law enforcement seizures tied to gas station or smoke shop sales.

Recent legislative sessions in states such as North Carolina, Florida and Pennsylvania have featured bills that either extend expiring emergency bans or convert them into permanent controls, reflecting concern that temporary measures alone are not enough to curb access.

Patchwork Regulation Leaves Enforcement Gaps

Despite the growing wave of bans, tianeptine remains available in many parts of the country, creating a patchwork of rules that complicates enforcement. News coverage from states that have enacted prohibitions describes situations where products labeled as containing tianeptine can still be found on shelves months after a law takes effect, often because retailers are unaware of the new status or suppliers continue to ship existing stock.

Compliance checks and retailer education campaigns have emerged as key tools for state and local officials trying to close these gaps. Some jurisdictions have circulated advisories to convenience stores and vape shops explaining that tianeptine is now a controlled substance and that selling it could lead to fines, license suspensions or criminal charges. In other cases, product seizures have occurred following inspections or consumer complaints.

The cross-border nature of retail supply chains adds another complication. Reports indicate that wholesalers sometimes route tianeptine products through neighboring states where bans are weaker or absent, allowing items to reenter markets that have attempted to restrict them. Online sales further blur these boundaries, enabling customers in regulated states to order products that ship from jurisdictions with looser rules.

Legal analysts observing the trend note that the lack of a unified federal classification leaves states to navigate their own definitions, penalties and exceptions. As a result, individuals who travel, move or purchase products online may find themselves unknowingly in violation of laws that vary widely from one state line to the next.

Travel, Public Health and Consumer Safety Implications

For travelers, the rapid expansion of emergency bans on tianeptine introduces a new layer of risk at routine stops along highways and tourist corridors. Convenience stores and gas stations, commonly used by visitors for quick purchases, may stock products that look like typical energy shots or wellness supplements but, in some regions, now fall under controlled substance rules.

Public health campaigns increasingly emphasize that travelers should be cautious with unfamiliar over-the-counter products, particularly those promising mood enhancement, pain relief or cognitive boosts. Poison center guidance suggests that anyone experiencing unexpected symptoms after using such items should seek medical attention and, when possible, bring the product packaging to help clinicians identify the substance involved.

Local news outlets have reported cases in which visitors or short-term residents purchased tianeptine products without realizing that they carried opioid-like risks or were restricted in that jurisdiction. These incidents have sharpened calls from some medical and advocacy groups for broader, more consistent regulations that would reduce confusion for both residents and tourists.

Travel-sector stakeholders, including chains that operate along interstate routes, are beginning to respond by reviewing product assortments and, in some cases, removing tianeptine-containing brands from their shelves, according to trade coverage. Such steps are framed as efforts to minimize liability and align with evolving state policies.

Pressure Builds for Broader Action

As more states move from emergency actions to permanent bans, national attention on “gas station morphine” continues to grow. Coverage from outlets including ABC News and regional public broadcasters has highlighted deaths and severe intoxications linked to tianeptine, fueling public debate over how a drug that behaves like an opioid can be sold alongside snacks and soft drinks.

Members of Congress have introduced proposals that would explicitly prohibit the sale of tianeptine nationwide or strengthen oversight of supplements that contain undisclosed pharmaceutical ingredients. While such measures have yet to produce a comprehensive federal ban, they signal rising concern in Washington about the proliferation of gas-station drugs with high abuse potential.

Regulatory analysts point out that tianeptine is part of a broader category of products marketed as legal highs or wellness enhancers that occupy gray areas in U.S. law. Similar debates have unfolded around synthetic cannabinoids, kratom and nitrous oxide, each prompting its own patchwork of state and local rules as evidence of harm accumulates.

For now, the expanding mosaic of emergency bans on tianeptine illustrates how quickly the legal landscape can shift in response to emerging drug trends. Travelers and consumers who encounter “gas station morphine” products face an environment in which a bottle or shot that is technically legal in one jurisdiction may be contraband a short drive away, underscoring the importance of caution when purchasing unregulated mood or energy boosters on the road.